Full Length Research Paper
References
|
Amarapurkar AD, Amarapurkar DN, Vibhav Patel ND (2007). Angiogenesis in chronic liver disease Annals Hepatol. 6:170- 173. Pubmed |
||||
| Amarapurkar D (2012). Clinical Care of patients with Cirrhosis. ESCAB Clinical Updates: Gastroenterolgy and Hepatology pp. 104-26. | ||||
|
Amarapurkar DN, Han KH, Chan HLY, Ueno Y (2009). Application of Surveillance Programs For Hepatocellular Carcinoma in the Asia Paciï¬c Region. J. Gastroenterol. Hepatol. 24:955–61 Crossref |
||||
|
Amin MA, Sabry D, Rashed LA, Aref WM, el-Ghobary MA, Farhan MS, Fouad HA, Youssef YA (2013). Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study. Clin. Transplant. 27(4):607- 12. Crossref |
||||
|
Asia Pacific Working Party on Prevention of Hepatocellular Carcinoma (2010). Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. J. Gastroenterol. Hepatol. 25:657-663 Crossref |
||||
|
Bosch J, Bergiotti A, Garcia Pagan JC, Abraldes JG (2008). The management of portal hypertension; rational basis, available treatment and future options. J. Hepatol. Suppl 1:S68-92. Crossref |
||||
|
Bruix J, Sherman M (2011). American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 53:1020-2. Crossref |
||||
| D’Amico G (2001). Natural history of compensated chirrosis and varices. In: TD Boyer & RK Groszmann (eds.), Complications of cirrhosis: pathogenesis, consequences and therapy. AASLD, Dallas. pp. 118-23, | ||||
|
European Association for the Study of the Liver. EASL (2010). Clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepato-renal syndrome in cirrhosis. J. Hepatol. 53:397–417 Crossref |
||||
|
Fogel MR, Knauer CM, Andres LL, Mahal AS, Stein DE, Kemeny MJ, Rinki MM, Walker JE, Siegmund D, Gregory PB (1982). Continuous intravenous vasopressin in active upper gastrointestinal bleeding. Ann. Intern. Med. 96:565-9. Crossref |
||||
|
Garcia-Tsao G, Bosch J (2010). Management of varices and variceal hemorrhage in cirrhosis. N. Engl. J. Med. 362:823–832 Crossref |
||||
|
Garcia-Tsao G, Friedman S, Iredale J, Pinzani M (2010). Now there are many (stages) where before there was one: In search of a Pathophysiological classification of cirrhosis. Hepatology 51:1445- 1449. Crossref |
||||
|
Garcia-Tsao G, Lim J, (2009). Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am. J. Gastroenterol. 104:1802–1829 Crossref |
||||
| Garciaâ€Tsao G, Sanyal AJ, Grace ND, Carey W (2007). Prevention and management of gastroesophageal varices and variceal hemorrhage Gastroenterol. 16:149-58. | ||||
|
Ginès A, Escorsell A, Ginès P, Saló J, Jiménez W, Inglada L, Navasa M, Clària J, Rimola A, Arroyo V (1993). Incidence, predictive factors, and prognosis of hepatorenal syndrome in cirrhosis. Gastroenterology 105:229–36 Pubmed |
||||
|
Grace JA, Angus PW (2013). Hepatopulmonary syndrome: update on recent advances in pathophysiology, investigation, and treatment. J. Gastroenterol. Hepatol. 28:213-9. Crossref |
||||
|
Kanwal F, Kramer JR, Buchanan P, Asch SM, Assioun Y, Bacon BR, Li J, El-Serag HB (2012). The Quality of Care Provided to Patients With Cirrhosis and Ascites in the Department of Veterans Affairs. Gastroenterology 143:70–77 Crossref |
||||
|
Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT (2001). A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 33(5):1060-4. Crossref |
||||
|
Mellinger JL, Volk ML (2013). Multidisciplinary management of patients with cirrhosis: a need for care coordination. Clin. Gastroenterol. 11(3):217-23. Crossref |
||||
|
O'Brien J, Triantos C, Burroughs AK (2013). Management of varices in patients with cirrhosis. Nat. Rev. Gastroenterol. Hepatol. In press. Crossref |
||||
|
Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK (2010). Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol. Int. 4:439- 74. Crossref |
||||
|
Porres-Aguilar M, Duarte-Rojo A, Krowka MJ (2013). Transthoracic echocardiography screening for the detection of portopulmonary hypertension: A work in progress. Liver Transplant. 19:573-4. Crossref |
||||
| Poustchi H, George J, Labio ED, Coverdale SA, Carney RG, Perry JF, et al. (2005). Screening for liver cancer: feasibility of a randomized controlled trial. Hepatology 42:376A | ||||
|
Runyon BA (2013). Management of adult patients with ascites due to cirrhosis: update 2012. Hepatology 57:1651-3. Crossref |
||||
|
Schuppan D, Afdhal NH (2008). Liver cirrhosis. Lancet 371:838-51 Crossref |
||||
|
Jansen PL (2002). Liver disease in the elderly. Best Pract. Res. Clin. 16: 149–158. Crossref |
||||
|
Tsochatzis EA, Bosch J, Burroughs AK (2012). New therapeutic paradigm for patients with cirrhosis. Hepatology 56:1983-92. Crossref |
||||
|
Wilbur K, Sidhu K (2005). Beta blocker prophylaxis for patients with variceal hemorrhage. J. Clin. Gastroenterol. 39(5):435-40. Crossref |
||||
|
Williams R (2006). Global challenges in liver disease. Hepatology 44:521-526. Crossref |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
